CN Stock MarketDetailed Quotes
000504 Landfar Bio-medicine
- 8.35
- -0.41-4.68%
Market Closed Dec 31 15:00 CST
2.76BMarket Cap-74.55P/E (TTM)
8.92High8.35Low43.01KlotVolume8.85Open8.76Pre Close36.94MTurnover1.39%Turnover RatioLossP/E (Static)330.02MShares11.3952wk High11.09P/B2.59BFloat Cap5.2652wk Low9.64Limit Up310.67MShs Float36.97Historical High7.88Limit Down6.51%Amplitude1.37Historical Low--Dividend TTM8.59Avg Price24.56KlotAsk--Div YieldTTM100Lot Size16.58KlotBid
Landfar Bio-medicine Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -11.78%92.42M | -20.03%56.32M | -25.23%25.97M | -31.72%136.79M | -33.02%104.76M | -35.84%70.43M | -46.40%34.74M | 27.92%200.35M | 52.40%156.4M | 62.87%109.78M |
| Operating revenue | -11.78%92.42M | -20.03%56.32M | -25.23%25.97M | -31.72%136.79M | -33.02%104.76M | -35.84%70.43M | -46.40%34.74M | 27.92%200.35M | 52.40%156.4M | 62.87%109.78M |
| Other operating revenue | ---- | -18.35%196.66K | ---- | -94.05%348.83K | ---- | -95.75%240.86K | ---- | 7,157.19%5.86M | ---- | --5.66M |
| Total operating cost | -15.92%95.17M | -18.01%62.13M | -16.29%29.98M | -24.07%157.38M | -25.74%113.19M | -31.32%75.77M | -46.82%35.81M | 18.15%207.27M | 40.69%152.42M | 56.49%110.32M |
| Operating cost | -14.04%29.54M | -17.25%19.62M | -15.29%9.21M | -38.07%43.69M | -43.43%34.37M | -52.26%23.71M | -69.38%10.87M | 54.41%70.54M | 282.60%60.75M | 338.53%49.67M |
| Operating tax surcharges | -18.27%638.14K | -11.51%438.46K | 1.83%217.54K | 8.77%1.22M | 0.43%780.81K | 8.94%495.48K | 17.21%213.64K | -13.68%1.12M | -9.53%777.44K | -24.34%454.8K |
| Operating expense | -17.66%22.81M | -18.54%15.01M | -15.21%7.41M | -36.45%38.4M | -24.63%27.7M | -25.46%18.42M | -34.33%8.74M | 4.77%60.43M | -12.63%36.75M | -7.93%24.72M |
| Administration expense | -3.27%35.38M | -5.09%23.08M | -10.47%10.59M | -2.26%52.39M | -4.24%36.58M | -0.70%24.31M | -7.97%11.82M | 11.13%53.6M | 15.87%38.2M | 15.33%24.48M |
| Financial expense | -103.43%-234.5K | -101.91%-85.42K | -81.12%370.99K | -21.37%9.11M | -24.55%6.83M | -32.95%4.46M | -46.12%1.96M | -17.17%11.59M | -9.44%9.05M | 10.44%6.65M |
| -Interest expense (Financial expense) | -83.75%1.24M | -84.30%817.17K | -74.11%709.47K | -14.20%11.07M | -23.23%7.65M | -22.62%5.21M | -29.90%2.74M | -8.59%12.9M | -14.90%9.97M | -13.68%6.73M |
| -Interest Income (Financial expense) | 0.29%-1.69M | 23.31%-1.07M | 52.13%-418.68K | -32.06%-2.35M | -29.58%-1.7M | -58.01%-1.39M | -118.41%-874.56K | 27.80%-1.78M | 35.54%-1.31M | 48.19%-880.89K |
| Research and development | 1.37%7.03M | -6.75%4.07M | -0.60%2.18M | 25.86%12.57M | 0.63%6.94M | 0.47%4.36M | 18.71%2.2M | 16.88%9.99M | 4.83%6.9M | -2.91%4.34M |
| Credit Impairment Loss | -131.28%-5.63M | -142.89%-5.92M | ---- | -35.67%-33.47M | -560.59%-2.44M | -571.02%-2.44M | ---- | -40.74%-24.67M | 150.01%528.85K | 148.90%517.13K |
| Asset Impairment Loss | -83,035.38%-1.96M | ---- | ---- | -227.38%-6.94M | -100.90%-2.36K | -727.78%-2.36K | ---- | 26.00%-2.12M | --263.12K | ---285 |
| Other net revenue | -135.39%-4.71M | -390.84%-5.26M | 68.62%1.53M | -30.66%-25.12M | 201.82%13.3M | -146.47%-1.07M | 2,810.90%908.55K | -62.25%-19.23M | 1,105.13%4.41M | 409.75%2.31M |
| Fair value change income | 61.68%-81.94K | -104.65%-168.42K | -468.36%-88.72K | 156.35%33.18K | 46.80%-213.83K | 71.65%-82.3K | 95.58%-15.61K | 62.13%-58.88K | -242.80%-401.92K | -185.02%-290.25K |
| Invest income | 165.42%2.09M | -22.98%444.04K | 531.74%1.36M | 23,776.68%920.55K | 656.15%787.24K | 311.57%576.55K | 177.42%214.73K | 102.46%3.86K | -66.83%-141.55K | -66.82%-272.51K |
| -Including: Investment income associates | -1,273.19%-60.72K | -61,493.63%-2.72M | ---- | 86.04%-68.51K | 95.37%-4.42K | 95.37%-4.42K | ---- | -51.54%-490.9K | 59.06%-95.47K | 59.06%-95.47K |
| Asset deal income | -102.66%-366.44K | ---- | ---- | 13,973.43%11.9M | 18,436.73%13.77M | -173.03%-54.25K | ---- | 186.18%84.59K | 1,491.40%74.27K | 1,491.71%74.28K |
| Other revenue | -10.68%1.25M | -58.76%382.27K | -62.77%264.12K | -67.78%2.43M | -65.80%1.4M | -59.30%926.83K | 18.78%709.42K | -14.65%7.53M | 394.03%4.08M | 290.13%2.28M |
| Operating profit | -253.25%-7.46M | -72.66%-11.06M | -1,389.25%-2.48M | -74.82%-45.71M | -42.00%4.87M | -463.60%-6.41M | 93.51%-166.24K | 14.73%-26.15M | 236.54%8.39M | 145.89%1.76M |
| Add:Non operating Income | -99.98%212.69 | -99.98%212.69 | ---- | -78.28%1.01M | -78.37%1.01M | -78.43%1M | 761.12%1M | 485.41%4.63M | 43.27%4.65M | 2,341.67%4.64M |
| Less:Non operating expense | 897.90%18.85K | 467.67%6.81K | 51.77%1.82K | -95.45%1.93K | -94.58%1.89K | -92.60%1.2K | -81.84%1.2K | -88.03%42.37K | -89.74%34.87K | -93.01%16.19K |
| Total profit | -227.34%-7.48M | -104.71%-11.07M | -397.58%-2.48M | -107.38%-44.71M | -54.87%5.87M | -184.66%-5.41M | 133.96%832.56K | 28.68%-21.56M | 501.89%13.01M | 264.54%6.38M |
| Less:Income tax cost | 21.51%1.41M | 35.45%563.35K | -6.52%368.97K | -73.80%2.07M | -76.05%1.16M | -83.42%415.92K | -49.79%394.69K | 174.94%7.9M | 128.54%4.85M | 107.76%2.51M |
| Net profit | -288.69%-8.89M | -99.77%-11.63M | -750.09%-2.85M | -58.79%-46.78M | -42.29%4.71M | -250.16%-5.82M | 113.52%437.87K | 11.00%-29.46M | 252.31%8.16M | 176.20%3.88M |
| Net profit from continuing operation | -288.69%-8.89M | -99.77%-11.63M | -750.09%-2.85M | -58.79%-46.78M | -42.29%4.71M | -250.16%-5.82M | 113.52%437.87K | 11.00%-29.46M | 252.31%8.16M | 176.20%3.88M |
| Less:Minority Profit | -111.25%-475.06K | -202.68%-3.24M | -103.14%-75.88K | -9.44%-18.61M | -44.58%4.22M | 84.34%3.15M | 171.05%2.41M | -21.66%-17M | 150.30%7.62M | 41.18%1.71M |
| Net profit of parent company owners | -1,828.05%-8.41M | 6.47%-8.39M | -40.21%-2.77M | -126.15%-28.17M | -9.99%486.72K | -514.10%-8.97M | -1,335.77%-1.98M | 34.87%-12.46M | 106.44%540.72K | 134.40%2.17M |
| Earning per share | ||||||||||
| Basic earning per share | -1,693.75%-0.0255 | 11.81%-0.0254 | -33.33%-0.0084 | -125.00%-0.09 | -5.88%0.0016 | -511.43%-0.0288 | -1,360.00%-0.0063 | 33.33%-0.04 | 106.30%0.0017 | 134.65%0.007 |
| Diluted earning per share | -1,693.75%-0.0255 | 11.81%-0.0254 | -33.33%-0.0084 | -125.00%-0.09 | -5.88%0.0016 | -511.43%-0.0288 | -1,360.00%-0.0063 | 33.33%-0.04 | 106.30%0.0017 | 134.65%0.007 |
| Other composite income | ||||||||||
| Total composite income | -288.69%-8.89M | -99.77%-11.63M | -750.09%-2.85M | -58.79%-46.78M | -42.29%4.71M | -250.16%-5.82M | 113.52%437.87K | 11.00%-29.46M | 252.31%8.16M | 176.20%3.88M |
| Total composite income of parent company owners | -1,828.05%-8.41M | 6.47%-8.39M | -40.21%-2.77M | -126.15%-28.17M | -9.99%486.72K | -514.10%-8.97M | -1,335.77%-1.98M | 34.87%-12.46M | 106.44%540.72K | 134.40%2.17M |
| Total composite income of minority owners | -111.25%-475.06K | -202.68%-3.24M | -103.14%-75.88K | -9.44%-18.61M | -44.58%4.22M | 84.34%3.15M | 171.05%2.41M | -21.66%-17M | 150.30%7.62M | 41.18%1.71M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
